Design and pharmacology of selective P2-purinoceptor antagonists

scientific article published on December 1996

Design and pharmacology of selective P2-purinoceptor antagonists is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1474-8673.1996.TB00049.X
P698PubMed publication ID9131412

P2093author name stringLambrecht G
P2860cites workPPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladderQ24685716
Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptorQ28637757
Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptorsQ34792562
Purinoceptors: are there families of P2X and P2Y purinoceptors?Q40510363
Identification of 6H1 as a P2Y purinoceptor: P2Y5.Q41229447
New insights on P2X purinoceptorsQ41367005
Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptorsQ41990163
PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptorsQ42026136
Vasoconstrictor responses to the P2x-purinoceptor agonist beta, gamma-methylene-L-ATP in human cutaneous and renal blood vesselsQ42056036
Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vesselsQ42702001
Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenumQ42708996
Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney.Q50538555
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
P304page(s)341-344
P577publication date1996-12-01
P1433published inAutonomic and Autacoid PharmacologyQ15754246
P1476titleDesign and pharmacology of selective P2-purinoceptor antagonists
P478volume16

Reverse relations

cites work (P2860)
Q44765828ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the guinea pig ileum.
Q46227712ATP-Induced Ca(2+) release in cochlear outer hair cells: localization of an inositol triphosphate-gated Ca(2+) store to the base of the sensory hair bundle.
Q48921231Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors
Q35952737Cellular distribution and functions of P2 receptor subtypes in different systems
Q35079713Chronic loss of noradrenergic tone produces β-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbens
Q33709273Connections between P2 purinoceptors and capsaicin-sensitive afferents in the intestine and other tissues
Q35057133Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive rats
Q24634206Crystal structure of coproporphyrinogen III oxidase reveals cofactor geometry of Radical SAM enzymes
Q42285459Dependence of P2-nucleotide receptor agonist-mediated endothelium-independent relaxation on ectonucleotidase activity and A2A-receptors in rat portal vein.
Q43793265Distinct mechanisms underlying alpha1-adrenoceptor and P2x purinoceptor operated ATP release and contraction in the guinea-pig vas deferens
Q36308607Evidence for a functional vasoconstrictor role for ATP in the human cutaneous microvasculature
Q36343279Evidence for the Recognition of Non-Nucleotide Antagonists Within the Transmembrane Domains of the Human P2Y(1) Receptor
Q46653860Extracellular adenosine 5'-triphosphate alters motility and improves the fertilizing capability of mouse sperm
Q44105475Immunoreactive localisation of P2Y1 receptors within the rat and human nodose ganglia and rat brainstem: comparison with [alpha 33P]deoxyadenosine 5'-triphosphate autoradiography
Q48618475Inhibitory neuromuscular transmission mediated by the P2Y1 purinergic receptor in guinea pig small intestine
Q54567650Mechanisms of alpha,beta-methylene atp-induced inhibition in rat ileal smooth muscle: involvement of intracellular Ca2+ stores in purinergic inhibition.
Q46745472NF279: a novel potent and selective antagonist of P2X receptor-mediated responses
Q28370919Neuronal soma-dendritic and prejunctional M1-M4 receptors in gastrointestinal and genitourinary smooth muscle
Q73155208Novel ligands for P2 receptor subtypes in innervated tissues
Q24533248P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels
Q43511074Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release.
Q42465968Purinergic inhibition of glucose transport in cardiomyocytes
Q43263816Stimulation of Ca(2+) influx through ATP receptors on rat brain synaptosomes: identification of functional P2X(7) receptor subtypes
Q45281019Stimulation of P2X receptors enhances lipooligosaccharide-mediated apoptosis of endothelial cells
Q37702209The P2X1 ion channel in platelet function
Q43263150The effect of P2 receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens
Q46273633The novel heteromeric bivalent ligand SB9 potently antagonizes P2Y(1) receptor-mediated responses
Q48900353The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors
Q50724270The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.